These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 4189411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Current treatment of severe tetanus].
    Sandu L.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1974; 23(9):787-96. PubMed ID: 4143223
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic consequences of immunologic reactions in manifest tetanus].
    Hiotakis K, Feischl P.
    Munch Med Wochenschr; 1971 Nov 19; 113(47):1591-5. PubMed ID: 4109151
    [No Abstract] [Full Text] [Related]

  • 7. [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].
    Auerswald W, Brücke P, Kucher R, Marsoner F, Müller H, Seidl H, Steinbereithner K, Wagner E.
    Wien Med Wochenschr; 1966 Mar 12; 116(11):229-35. PubMed ID: 4168478
    [No Abstract] [Full Text] [Related]

  • 8. An approach to prognosis and treatment of tetanus: with special reference to tetanus in Kampala-Uganda.
    Masawe AE.
    East Afr Med J; 1973 Dec 12; 50(12):727-37. PubMed ID: 4788330
    [No Abstract] [Full Text] [Related]

  • 9. [Use of human immunoglobulin in tetanus].
    Burkhardt G, Starke G, Seifart W.
    Zentralbl Chir; 1970 Feb 07; 95(6):180-4. PubMed ID: 4104896
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The treatment of neonatal tetanus with hyperimmune gamma globulins].
    Crimaldi A, Jemma R.
    Pediatria (Napoli); 1973 Oct 31; 81(3):482-9. PubMed ID: 4129131
    [No Abstract] [Full Text] [Related]

  • 12. COMBINED ACTIVE-PASSIVE IMMUNIZATION AGAINST TETANUS WITH HUMAN IMMUNE GLOBULIN.
    RUBBON SD, SURI JC.
    Med J Aust; 1965 Jul 17; 2(3):109-13. PubMed ID: 14335896
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [On prevention of tetanus].
    Bernasconi A, Vespasiani A.
    Minerva Ortop; 1970 Jul 17; 21(6):413-6. PubMed ID: 4101692
    [No Abstract] [Full Text] [Related]

  • 15. [Recurrent tetanus. Clinical, immunological and therapeutic considerations].
    Warter J, Mantz JM, Tempe JD, Otteni JC.
    Presse Med (1893); 1967 May 20; 75(24):1223-6. PubMed ID: 6024174
    [No Abstract] [Full Text] [Related]

  • 16. Active-passive tetanus immunization. Choice of toxoid, dose of tetanus immune globulin and timing of injections.
    Levine L, McComb JA, Dwyer RC, Latham WC.
    N Engl J Med; 1966 Jan 27; 274(4):186-90. PubMed ID: 4159253
    [No Abstract] [Full Text] [Related]

  • 17. [Human antitetanus gamma globulins].
    Herzog F, Gaiffe M, Badillet M.
    Presse Med (1893); 1969 Feb 01; 77(6):207-8. PubMed ID: 4182144
    [No Abstract] [Full Text] [Related]

  • 18. [Specific human immunoglobulins and anatoxin in the treatment of tetanus: possible interference with the immune response].
    Carcó FP, Cerruti Mainardi P, Fresia A.
    Clin Ter; 1977 Apr 30; 81(2):131-8. PubMed ID: 872529
    [No Abstract] [Full Text] [Related]

  • 19. [Antitetanus prophylaxis: actual practice and cost benefit analysis of a hypothetical mass vaccination].
    Palombino R, Greco M, Morra G, Pitzurra M.
    Boll Ist Sieroter Milan; 1987 Apr 30; 66(5):402-10. PubMed ID: 3449103
    [Abstract] [Full Text] [Related]

  • 20. [Antitetanic vaccination].
    del Piano M.
    Nuovi Ann Ig Microbiol; 1975 Apr 30; 26(2-3):87-125. PubMed ID: 1219643
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.